Global Andrographolide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Andrographolide Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Andrographolide Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Andrographolide Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Andrographolide Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Andrographolide Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Andrographolide Tablets include Guangdong Wannianqing Pharmaceutical Co., Ltd., Sinopharm Group Yibin Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Quanzhou Zhongqiao Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd. and Chongqing Kerui Pharmaceutical (Group) Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Andrographolide Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Andrographolide Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Andrographolide Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Andrographolide Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Andrographolide Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Andrographolide Tablets sales, projected growth trends, production technology, application and end-user industry.


Andrographolide Tablets Segment by Company

Guangdong Wannianqing Pharmaceutical Co., Ltd.
Sinopharm Group Yibin Pharmaceutical Co., Ltd.
Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
Henan Furentang Pharmaceutical Co., Ltd.
Hubei Keyi Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Co., Ltd.
Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Andrographolide Tablets Segment by Type

Dispersible Tablets
Conventional Tablets

Andrographolide Tablets Segment by Application

Hospital
Clinic
Other

Andrographolide Tablets Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Andrographolide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Andrographolide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Andrographolide Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Andrographolide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Andrographolide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Andrographolide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Andrographolide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Andrographolide Tablets Market Size, 2020 VS 2024 VS 2031
1.3 Global Andrographolide Tablets Market Size Estimates and Forecasts (2020-2031)
1.4 Global Andrographolide Tablets Sales Estimates and Forecasts (2020-2031)
1.5 Global Andrographolide Tablets Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Andrographolide Tablets Market Dynamics
2.1 Andrographolide Tablets Industry Trends
2.2 Andrographolide Tablets Industry Drivers
2.3 Andrographolide Tablets Industry Opportunities and Challenges
2.4 Andrographolide Tablets Industry Restraints
3 Andrographolide Tablets Market by Manufacturers
3.1 Global Andrographolide Tablets Revenue by Manufacturers (2020-2025)
3.2 Global Andrographolide Tablets Sales by Manufacturers (2020-2025)
3.3 Global Andrographolide Tablets Average Sales Price by Manufacturers (2020-2025)
3.4 Global Andrographolide Tablets Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Andrographolide Tablets Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Andrographolide Tablets Manufacturers, Product Type & Application
3.7 Global Andrographolide Tablets Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Andrographolide Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Andrographolide Tablets Players Market Share by Revenue in 2024
3.8.3 2024 Andrographolide Tablets Tier 1, Tier 2, and Tier 3
4 Andrographolide Tablets Market by Type
4.1 Andrographolide Tablets Type Introduction
4.1.1 Dispersible Tablets
4.1.2 Conventional Tablets
4.2 Global Andrographolide Tablets Sales by Type
4.2.1 Global Andrographolide Tablets Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Andrographolide Tablets Sales by Type (2020-2031)
4.2.3 Global Andrographolide Tablets Sales Market Share by Type (2020-2031)
4.3 Global Andrographolide Tablets Revenue by Type
4.3.1 Global Andrographolide Tablets Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Andrographolide Tablets Revenue by Type (2020-2031)
4.3.3 Global Andrographolide Tablets Revenue Market Share by Type (2020-2031)
5 Andrographolide Tablets Market by Application
5.1 Andrographolide Tablets Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Andrographolide Tablets Sales by Application
5.2.1 Global Andrographolide Tablets Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Andrographolide Tablets Sales by Application (2020-2031)
5.2.3 Global Andrographolide Tablets Sales Market Share by Application (2020-2031)
5.3 Global Andrographolide Tablets Revenue by Application
5.3.1 Global Andrographolide Tablets Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Andrographolide Tablets Revenue by Application (2020-2031)
5.3.3 Global Andrographolide Tablets Revenue Market Share by Application (2020-2031)
6 Global Andrographolide Tablets Sales by Region
6.1 Global Andrographolide Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Andrographolide Tablets Sales by Region (2020-2031)
6.2.1 Global Andrographolide Tablets Sales by Region (2020-2025)
6.2.2 Global Andrographolide Tablets Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Andrographolide Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Andrographolide Tablets Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Andrographolide Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Andrographolide Tablets Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Andrographolide Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Andrographolide Tablets Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Andrographolide Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Andrographolide Tablets Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Andrographolide Tablets Revenue by Region
7.1 Global Andrographolide Tablets Revenue by Region
7.1.1 Global Andrographolide Tablets Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Andrographolide Tablets Revenue by Region (2020-2025)
7.1.3 Global Andrographolide Tablets Revenue by Region (2026-2031)
7.1.4 Global Andrographolide Tablets Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Andrographolide Tablets Revenue (2020-2031)
7.2.2 North America Andrographolide Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Andrographolide Tablets Revenue (2020-2031)
7.3.2 Europe Andrographolide Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Andrographolide Tablets Revenue (2020-2031)
7.4.2 Asia-Pacific Andrographolide Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Andrographolide Tablets Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Andrographolide Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Guangdong Wannianqing Pharmaceutical Co., Ltd.
8.1.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Comapny Information
8.1.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview
8.1.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
8.1.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments
8.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
8.2.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Comapny Information
8.2.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
8.2.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
8.2.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
8.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
8.3.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Comapny Information
8.3.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview
8.3.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio
8.3.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments
8.4 Henan Furentang Pharmaceutical Co., Ltd.
8.4.1 Henan Furentang Pharmaceutical Co., Ltd. Comapny Information
8.4.2 Henan Furentang Pharmaceutical Co., Ltd. Business Overview
8.4.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
8.4.5 Henan Furentang Pharmaceutical Co., Ltd. Recent Developments
8.5 Hubei Keyi Pharmaceutical Co., Ltd.
8.5.1 Hubei Keyi Pharmaceutical Co., Ltd. Comapny Information
8.5.2 Hubei Keyi Pharmaceutical Co., Ltd. Business Overview
8.5.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
8.5.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments
8.6 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
8.6.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Comapny Information
8.6.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview
8.6.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
8.6.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments
8.7 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
8.7.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Comapny Information
8.7.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview
8.7.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
8.7.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments
8.8 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
8.8.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Comapny Information
8.8.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview
8.8.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
8.8.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments
8.9 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
8.9.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Comapny Information
8.9.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
8.9.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio
8.9.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Andrographolide Tablets Value Chain Analysis
9.1.1 Andrographolide Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Andrographolide Tablets Production Mode & Process
9.2 Andrographolide Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Andrographolide Tablets Distributors
9.2.3 Andrographolide Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings